AZCOBA
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Feb 2032: the §71 affidavit of use).
Record
- Serial number
- 79420541
- Registration number
- 8122626
- Mark type
- Word mark
- Filed
- 21 Feb 2025
- Published for opposition
- 16 Dec 2025
- Registered
- 03 Feb 2026
- Next maintenance filing
- §71 affidavit of use, due by 03 Feb 2032 (grace period to 03 Aug 2032)
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; immunomodulators and immunosuppressive agents being pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology
Owner
- TAIHO PHARMACEUTICAL CO., LTD., Chiyoda-ku, Tokyo, JP
- TAIHO PHARMACEUTICAL CO., LTD., Chiyoda-ku, Tokyo, JP
- TAIHO PHARMACEUTICAL CO., LTD., Chiyoda-ku, Tokyo, JP
Prosecution history
- 17 Sept 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Sept 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Sept 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Sept 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 13 Aug 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Aug 2026 — FINAL DISPOSITION PROCESSED
- 23 Jun 2026 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 29 May 2026 — CORRECTION UNDER SECTION 7 - PROCESSED
- 18 May 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 May 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Feb 2026 — TEAS SECTION 7 REQUEST RECEIVED
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION